Cancer Care has become a major industry with a three-digit billion dollar market size wherein big pharma and medical companies are on top.
Good diagnostics with respect to early detection and correct stratification are most certainly part of a notable solution.But the reality of cancer diagnostic tests is that it is not being up to the task.
He is setting a benchmark through his consistent efforts in cell separation and diagnostic test development.Basically, he wanted to develop assays in the field of general magnetic particle-based cell separation technology.
At that time the start-up managed to raise funds by making a pitch at the Y-combinator in the US at the end of 2014.However, the team lost its cohesive approach towards the work.
This marked the intent to commercialize one invention and was reason enough for his current partners to be on board for kick-starting the project, later called SanoLiBio.A Life-changing ProjectSanoLiBio is a german based start-up that is focused on the enrichment of rare cells in general and circulating tumor cells (CTCs) in particular taken from the liquid biopsy.
This Medtech start-up is currently at an infant stage in the liquid biopsy industry.